TrialAntimicrobial agents and chemotherapy2018

Pharmacokinetic and Pharmacodynamic Analyses To Determine the Optimal Fixed Dosing Regimen of Iclaprim for Treatment of Patients with Serious Infections Caused by Gram-Positive Pathogens.

Thomas P Lodise et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.